Is Ki-67 Proliferation Index at all relevant
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Ki-67 Proliferation Index Relevance for Josh's Case
Based on the document provided, Ki-67 proliferation index is not mentioned in Josh's clinical summary. However, I can address whether it would be relevant to his situation:
Why It Could Be Relevant
Ki-67 is a marker that measures how quickly cancer cells are dividing. According to NCCN Guidelines for Non-Hodgkin's Lymphomas, Ki-67 can help:
- Assess the aggressiveness of follicular lymphoma
- Help predict treatment response and prognosis
- Guide treatment selection
Since Josh has relapsed/refractory follicular lymphoma with documented disease progression, Ki-67 could potentially provide useful information about his tumor's behavior.
What the Document Shows Instead
The clinical summary notes that:
- Specific genomic mutations, BRCA status, IHC results, and methylation data are not provided in the available records
- Tissue from his recent splenectomy is available for molecular testing
- An upcoming biopsy is scheduled for [date removed]
Next Steps to Consider
Since Josh has tissue available and an upcoming biopsy, this would be an appropriate time to discuss with his oncology team whether comprehensive molecular profiling—which could include Ki-67 assessment—should be performed to help guide future treatment decisions.
I'd recommend Josh ask his care team directly about what biomarkers they plan to test on the upcoming biopsy tissue.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ